Highlights and Quick Summary
- Depreciation & Amortization Growth for the quarter ending December 31, 2022 was -70.47% (a 28.15% increase compared to previous quarter)
- Year-over-year quarterly Depreciation & Amortization Growth increased by 122.16%
- Annual Depreciation & Amortization Growth for 2022 was -50.91% (a 81.56% increase from previous year)
- Annual Depreciation & Amortization Growth for 2021 was -28.04% (a -58.3% decrease from previous year)
- Annual Depreciation & Amortization Growth for 2020 was -67.24% (a -196.85% decrease from previous year)
- Twelve month Depreciation & Amortization Growth ending December 31, 2022 was -50.91% (a 56.21% increase compared to previous quarter)
- Twelve month trailing Depreciation & Amortization Growth increased by 59.79% year-over-year
Trailing Depreciation & Amortization Growth for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| -50.91% | -32.59% | -18.04% | -31.86% |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Depreciation & Amortization Growth of Precigen, Inc.
Most recent Depreciation & Amortization Growthof PGEN including historical data for past 10 years.Interactive Chart of Depreciation & Amortization Growth of Precigen, Inc.
Precigen, Inc. Depreciation & Amortization Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -70.47% | -54.99% | -45.31% | -31.72% | -50.91% |
| 2021 | 3.12% | 2.15% | -59.13% | -12.07% | -28.04% |
| 2020 | -92.81% | -41.77% | 580.56% | -13.96% | -67.24% |
| 2019 | 639.0% | -34.36% | -91.12% | -11.71% | 69.43% |
| 2018 | -17.35% | 195.64% | 2701.6% | 2.8% | 130.99% |
| 2017 | -27.68% | 1.05% | -103.57% | -67.42% | -65.73% |
| 2016 | 506.56% | -83.52% | 21.57% | 125.32% | 274.33% |
| 2015 | 109.8% | -12.63% | -32.2% | -467.33% | -318.03% |
| 2014 | -1271.3% | 259.68% | 716.43% | -163.07% | 981.88% |
| 2013 | -112.45% | -522.58% | 51.41% | 345.65% | -117.67% |
| 2012 | 903.36% | 123.66% | -105.78% | – | 103.54% |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology